Ravid and colleagues found that pretreatment of MCF-7 breast cancer cells with VD significantly reduces both the expression and activity of Cu/Zn superoxide dismutase (Cu/Zn SOD), suggesting an increased sensitivity of cancer cells to ROS species [43,44]. Here, SOD1 is linked to breast carcinoma.